XBiotech XBIT
NASDAQ XBIT
$2.31 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

XBiotech (XBIT) EBT Margin Growth (1y) (2021 - 2022)

XBiotech (XBIT) EBT Margin Growth (1y) (2021 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -153.00
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -571.00
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 546.00
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 4,709.00
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1,076.00
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1,911.00
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 29,565.00
8 Royalty Pharma 26.98 Bn 26.14 Bn - -392.00
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -2,507.00
10 XBiotech 68.90 Mn 68.90 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 -49,867.00
Jun 30, 2022 -71,734.00
Mar 31, 2022 -122,802.00
Sep 30, 2021 -8,158.00
Jun 30, 2021 -16,786.00
Mar 31, 2021 -5,990.00